On ECHEMI
Home > Drugs > Shandong Hualu Pharmaceutical Co., Ltd.
Shandong Hualu Pharmaceutical Co., Ltd.
  • Founded in:

    1998-11-28
  • Country:

    China China
  • Address:

    No. 1 Hualu Street, Zhenxing Street, Chiping District, Liaocheng City, Shandong Province
  • Tax NO.:

    91371523168091268M
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Sodium Glucuronate Injection
The main ingredient is sodium glucuronate.
Name Description Content CAS NO. Registered Holders
D-Glucuronic acid sodium salt

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

More

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

14984-34-0 0
Procaine Hydrochloride
Name Description Content CAS NO. Registered Holders
Procaine hydrochloride

51-05-8 11
Lidocaine Hydrochloride
Name Description Content CAS NO. Registered Holders
Lidocaine hydrochloride

Extract from the above information

More

Extract from the above information

6108-05-0 46
Droperidol injection
The main ingredient of this product is droperidol, and its chemical name is: 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridinyl]-2-benzimidazolinone.
Name Description Content CAS NO. Registered Holders
DROPERIDOL

The antipsychotic effect is related to its ability to block dopamine receptors in the brain and promote the conversion of dopamine in the brain. It is characterized by rapid metabolism in the body, short-lasting effects, and sedative and analgesic effects.

More

The antipsychotic effect is related to its ability to block dopamine receptors in the brain and promote the conversion of dopamine in the brain. It is characterized by rapid metabolism in the body, short-lasting effects, and sedative and analgesic effects.

548-73-2 11
Betahistine Hydrochloride and Sodium Chloride Injection
Betahistine hydrochloride sodium chloride. Its chemical name is: N-methyl-2-pyridineethylamine dihydrochloride. Molecular formula: C8H12N22HC1
Name Description Content CAS NO. Registered Holders
Betahistine dihydrochloride

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

More

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

5579-84-0 20
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.